Here are five observations:
1. The market is set to drop from $72 million in 2016 to $29.4 million by 2023.
2. Analysts noted procedure adoption is inconsistent because of sparse data demonstrating vertebroplasty’s efficacy.
3. The risk of cement leakage and damage to the surrounding spinal canal and nerves deters wide adoption of the procedure.
4. In developing markets such as the Middle East and Africa, however, the market will likely grow at a compound annual growth rate of 6.8 percent through 2023. This growth is due to the cost-effectiveness of the procedure.
5. DePuy Synthes, Medtronic and Stryker account for about 80 percent of the market share.
More articles on spine:
4 trends in back pain patient referrals to physical therapy
Dr. Anthony Yeung: Why spine is moving toward endoscopic surgery
6 spine surgeons & neurosurgeons on the move in April 2017
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.